143 related articles for article (PubMed ID: 35872619)
1. Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors.
Lu Z; Teng Y; Ning X; Wang H; Feng W; Ou C
Cancer; 2022 Sep; 128(18):3330-3339. PubMed ID: 35872619
[TBL] [Abstract][Full Text] [Related]
2. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
3. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
[TBL] [Abstract][Full Text] [Related]
5. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.
Dores GM; Curtis RE; Dalal NH; Linet MS; Morton LM
J Clin Oncol; 2020 Dec; 38(35):4149-4162. PubMed ID: 32946352
[TBL] [Abstract][Full Text] [Related]
6. Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma.
Wang F
Medicine (Baltimore); 2022 Dec; 101(48):e31967. PubMed ID: 36482535
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults.
Xavier AC; Epperla N; Taub JW; Costa LJ
Am J Hematol; 2018 Feb; 93(2):238-245. PubMed ID: 29114948
[TBL] [Abstract][Full Text] [Related]
10. Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
Oliva S; Puzzovivo A; Gerardi C; Allocati E; De Sanctis V; Minoia C; Skrypets T; Guarini A; Gini G
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008222
[TBL] [Abstract][Full Text] [Related]
11. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
12. Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: an American population-based cohort study.
Wang L; Wang F; Chen L; Geng Y; Yu S; Chen Z
Eur Heart J; 2021 Jan; 42(1):101-109. PubMed ID: 33156911
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
Bröckelmann PJ; Goergen H; Keller U; Meissner J; Ordemann R; Halbsguth TV; Sasse S; Sökler M; Kerkhoff A; Mathas S; Hüttmann A; Bormann M; Zimmermann A; Mettler J; Fuchs M; von Tresckow B; Baues C; Rosenwald A; Klapper W; Kobe C; Borchmann P; Engert A
JAMA Oncol; 2020 Jun; 6(6):872-880. PubMed ID: 32352505
[TBL] [Abstract][Full Text] [Related]
15. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
Ramin C; Schaeffer ML; Zheng Z; Connor AE; Hoffman-Bolton J; Lau B; Visvanathan K
J Natl Cancer Inst; 2021 Feb; 113(2):137-145. PubMed ID: 32634223
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
Tawfiq E; Pylypchuk R; Elwood JM; McKeage M; Wells S; Selak V
Cancer Med; 2023 Oct; 12(19):20081-20093. PubMed ID: 37746882
[TBL] [Abstract][Full Text] [Related]
17. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
Felix AS; Bower JK; Pfeiffer RM; Raman SV; Cohn DE; Sherman ME
Int J Cancer; 2017 Feb; 140(3):555-564. PubMed ID: 27741565
[TBL] [Abstract][Full Text] [Related]
18. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
19. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
